Rule 144 filing shows planned IQV (NYSE: IQV) share sale

Rhea-AI Filing Summary

A planned Rule 144 sale has been filed for IQV common stock. The notice covers 36564 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of 8132875.67, while 170300000 shares are outstanding. The approximate sale date listed is 12/18/2025 on the NYSE.

The filing also discloses that Ari Bousbib sold 56557 common shares of the same issuer on 10/29/2025, generating gross proceeds of 12460983.24. These details show both the upcoming planned transaction and recent sales over the prior three months, as required under Rule 144 disclosure rules.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	36564	8132875.67	170300000	12/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/18/2025	Stock Appreciation Rights	Issuer			36564	12/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ARI BOUSBIB 2400 Ellis Rd. Durham, NC 27703	Common	10/29/2025	56557	12460983.24

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Rule 144 notice for IQV disclose?

The notice discloses a planned sale of 36564 common shares of the issuer’s stock, with an aggregate market value of 8132875.67, to be sold on the NYSE around 12/18/2025 through Morgan Stanley Smith Barney LLC.

How many IQV shares are covered by the new planned sale?

The filing covers 36564 common shares of the issuer’s stock to be sold under Rule 144.

What is the aggregate market value of the IQV shares to be sold?

The planned Rule 144 transaction lists an aggregate market value of 8132875.67 for the 36564 common shares to be sold.

How many IQV shares are outstanding according to this notice?

The notice states that there are 170300000 common shares outstanding for the issuer.

What IQV share sales occurred in the past three months?

The filing reports that Ari Bousbib sold 56557 common shares on 10/29/2025, generating gross proceeds of 12460983.24.

Which broker is handling the planned IQV Rule 144 sale?

The broker listed for the planned sale is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.